Cerevel Therapeutics Inc (CERE) - Forvard narx/daromad multiplikatori
Cerevel Therapeutics (CERE) Altsgeymer va shizofreniyaga qarshi kurashish uchun maqsadli molekulalarni ishlab chiqadi. Brend sog'liqni saqlash giganti tomonidan sotib olinganidan so'ng, ishonchli klinik yetakchi sifatidagi maqomini mustahkamladi. Yuqori R&D salohiyati Parkinson kasalligi uchun retseptorlar bioingeneriyasiga qaratilgan. GURU.Markets terminalining chiziqli grafigidagi prognoz qilingan P/S dinamikasi biznesning baholanishini vizuallashtiradi, bunda ushbu ko'rsatkichning eng so'nggi qiymatini aks ettiradi.
Cerevel Therapeutics (CERE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- biznesning balans baholash tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Cerevel Therapeutics|CERE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati cerevel.com|CERE - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Cerevel Therapeutics|CERE - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari Cerevel Therapeutics|Tezkor likvidlik ko‘rsatkichi cerevel.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
CERE - Sof foyda|Kelajakdagi foyda Cerevel Therapeutics|CERE - Bozor narxining sof foydaga nisbati|Forvard P/E multiplikatori cerevel.com|CERE - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|EV/EBITDA multiplikatori Cerevel Therapeutics Inc|CERE - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Cerevel Therapeutics|CERE - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi cerevel.com|CERE - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Cerevel Therapeutics
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning fundamental tahlili:CERE (Cerevel Therapeutics, Inc.)
Oldingi P/S koeffitsiyenti kompaniyaning bozor qiymatini uning kutilayotgan daromadlariga nisbatan baholaydi, bu esa investorlarga talabning potentsial pasayishi sharoitida aktivlarning haddan tashqari qimmat baholanganlik darajasini aniqlash imkonini beradi. Prognoz qilingan P/S multiplikatorini tahlil qilish orqali Cerevel Therapeutics (CERE) kompaniyasining adolatli qiymatini baholash mumkin, uning turli sinov bosqichlaridagi neyropsixiatrik dori vositalarini diversifikatsiyalashgan holda ishlab chiqishi, pipeline mahsulotlarining tijoratlashtirilishini kutish vaqtida kapital to'xtab qolish xavfini minimallashtiradi.
Toʻgʻridan-toʻgʻri raqobatchilar
Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|Neumora Corp (NMRA) - Narxning prognoz qilingan daromadga nisbati|Scilex Holding Company, Inc. (SCLX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TVGN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Inc. ACOG|Narxning prognoz qilingan daromadga nisbati cogrx.com (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Inhibikase Therapeutics, Inc.|Forvard P/S multiplikatori SAVA (Cassava Sciences Inc)|Forvard P/S multiplikatori Assertio Holdings, Inc. ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati Vistagen (VTGN)|OVID: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Acumen Pharmaceuticals Inc. (ABOS)|Forvard narx/daromad multiplikatori CRVO|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATHE (Alterity Therapeutics)|Narxning prognoz qilingan daromadga nisbati Clene Nanomedicine (CLNN)|PEPG (PepGen) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|Sotuvga nisbatan forvard narx RLMD|ANVS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics Inc|AIFF: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences Inc (KLTO)|Narxning prognoz qilingan daromadga nisbati neurosense-tx.com|Bozor kapitallashuvining kelajakdagi daromadga nisbati Reviva Pharmaceuticals Holdings Inc. RVPH|Narxning prognoz qilingan daromadga nisbati MetaVia Inc. (MTVA)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati NeurAxis Inc|Forvard P/S multiplikatori HSDT (heliusmedical.com)|Sotuvga nisbatan forvard narx PASG|NEUP: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Minerva Neurosciences Inc|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Addex Therapeutics, Ltd. - Sotuvga nisbatan forvard narx|ALZN (Alzamend Neuro) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati cyclerion.com CYCN|Forvard P/S multiplikatori PTIX|KTTA - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics Inc (ATXI) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|BCLI - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati caratherapeutics.com|CHRO: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Eliem Therapeutics (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Longboard|Forvard P/S multiplikatori MRNS|Kapitalizatsiyaning kutilayotgan sotuvga nisbati nkgenbiotech.com|Forvard P/S multiplikatori NRBO (neurobopharma.com)|Sage Therapeutics, Inc (SAGE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SNPX - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx TRVN (Trevena, Inc)|VIGL: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati anewmeds.com (WENA)
